Delayed immune‐mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long‐term follow‐up and review of the literature
Identifieur interne : 001A12 ( Main/Exploration ); précédent : 001A11; suivant : 001A13Delayed immune‐mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long‐term follow‐up and review of the literature
Auteurs : J. Alijotas-Reig [Espagne] ; V. Garcia-Gimenez [Espagne]Source :
- Journal of the European Academy of Dermatology and Venereology [ 0926-9959 ] ; 2008-02.
English descriptors
- Teeft :
- Acad dermatol, Acrylic hydrogel, Adverse effects, Adverse reactions, Aesthetic surg, Arch dermatol, Augmentation, Authors jeadv, Autoimmune, Case number, Cosmetic, Cutaneous, Dermal, Dermalive, Dermaliver, Dermatol, Dermatol surg, Dermatology, European academy, Facial, Facial oedema, Granuloma, Granulomatous, Granulomatous reactions, Histological, Hyaluronic, Hyaluronic acid, Hypersensitivity, Hypersensitivity reactions, Implant, Injectable, Jeadv, Journal compilation, Juvederm, Lled, Ller, Ller material, Llers, Nasha, Nodule, Oedema, Other hand, Patient number, Plast, Plast reconstr surg, Recurrent bouts, Restylane, Restylaner, Rooster combs, Sarcoidosis, Sicca, Sicca syndrome, Silicone, Skin lesions, Soft tissue augmentation, Surg, Syndrome, Systemic complaints, Systemic manifestations, Vasculitis, Venereology.
Abstract
Introduction Implantation of dermal filler for cosmetic purposes is becoming increasingly common worldwide. It is thought that hyaluronic acid (HA) alone or combined with acrylic hydrogels (HA‐AH) does not have severe nor persistent side‐effects. However, recent evidence may show that major, local and/or systemic, immediate or delayed adverse effects may appear in relation with its use. Objective To evaluate the clinical complaints, laboratory data, treatment and follow‐up of patients with delayed adverse effects related to HA and HA‐AH implant fillers. Design Prospective, case‐series study of patients filled with HA and HA‐AH compounds. Setting The study has been done in a tertiary, teaching university hospital. Patients We report on a series of 25 patients, 15 of them in prospective manner, with severe, delayed side‐effects related to HA‐AH. Inclusion criteria have been drawn up. Patients with immediate side‐effects were excluded. Patients were submitted to a clinical follow‐up, battery of blood tests and thorax X‐ray films. Besides, a review of the literature was made. We undertook a computed‐assisted (MEDLINE), National Library of Medicine, Bethesda, MD, USA, search of the literature from 1996 up to December 2005. Main outcome Clinical evaluation of granulomas, skin manifestations and other local and systemic immune‐mediated disorders possibly related to HA and HA‐AH fillers or their cumulative interaction with previously administered fillers. Results Of 25 cases, 16 were filled with HA alone and 9 with a HA‐AH compounds. Of 15 cases analysed and with long‐term follow‐up, 10 were filled with HA alone, and the remaining five were filled with a HA‐AH. Time latency average up to beginning of symptoms was 13.7 months. Three of these 15 cases had been filled before with silicone and another one with Artecoll. Tender nodules were seen in 14 patients. Systemic manifestations appeared in three cases. Laboratory abnormalities were noted in all studied cases. After 16‐month average follow‐up, seven patients seem to be cured, and six have recurrent bouts. Two cases were lost during follow‐up. Conclusion Although in some cases, these clinical complications might have been associated with previous fillers or with other unknown foreign bodies, we feel that, although infrequently, delayed and recurrent chronic inflammatory and granulomatous reactions may complicate HA and HA‐AH implant fillers.
Url:
DOI: 10.1111/j.1468-3083.2007.02354.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000427
- to stream Istex, to step Curation: 000427
- to stream Istex, to step Checkpoint: 000917
- to stream Main, to step Merge: 001A20
- to stream Main, to step Curation: 001A12
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Delayed immune‐mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long‐term follow‐up and review of the literature</title>
<author><name sortKey="Alijotas Eig, J" sort="Alijotas Eig, J" uniqKey="Alijotas Eig J" first="J" last="Alijotas-Reig">J. Alijotas-Reig</name>
</author>
<author><name sortKey="Garcia Imenez, V" sort="Garcia Imenez, V" uniqKey="Garcia Imenez V" first="V" last="Garcia-Gimenez">V. Garcia-Gimenez</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:17C84C26C6687775A7EDAF453BE1784DECA9F79C</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1111/j.1468-3083.2007.02354.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-F7LM3W6K-X/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000427</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000427</idno>
<idno type="wicri:Area/Istex/Curation">000427</idno>
<idno type="wicri:Area/Istex/Checkpoint">000917</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000917</idno>
<idno type="wicri:doubleKey">0926-9959:2008:Alijotas Eig J:delayed:immune:mediated</idno>
<idno type="wicri:Area/Main/Merge">001A20</idno>
<idno type="wicri:Area/Main/Curation">001A12</idno>
<idno type="wicri:Area/Main/Exploration">001A12</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Delayed immune‐mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long‐term follow‐up and review of the literature</title>
<author><name sortKey="Alijotas Eig, J" sort="Alijotas Eig, J" uniqKey="Alijotas Eig J" first="J" last="Alijotas-Reig">J. Alijotas-Reig</name>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea> Ageing Research and Autoimmune Diseases Unit, Department of Internal Medicine I, Hospital Universitari Vall d’Hebron, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Medicine, Universitat Autonoma, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Espagne</country>
</affiliation>
</author>
<author><name sortKey="Garcia Imenez, V" sort="Garcia Imenez, V" uniqKey="Garcia Imenez V" first="V" last="Garcia-Gimenez">V. Garcia-Gimenez</name>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea> Europa Medical Centre, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea> Sociedad Española de Medicina y Cirugia Cosmética, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of the European Academy of Dermatology and Venereology</title>
<title level="j" type="alt">JOURNAL OF EUROPEAN ACADEMY DERMATOLOGY VENEREOLOGY</title>
<idno type="ISSN">0926-9959</idno>
<idno type="eISSN">1468-3083</idno>
<imprint><biblScope unit="vol">22</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="150">150</biblScope>
<biblScope unit="page" to="161">161</biblScope>
<biblScope unit="page-count">12</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2008-02">2008-02</date>
</imprint>
<idno type="ISSN">0926-9959</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0926-9959</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad dermatol</term>
<term>Acrylic hydrogel</term>
<term>Adverse effects</term>
<term>Adverse reactions</term>
<term>Aesthetic surg</term>
<term>Arch dermatol</term>
<term>Augmentation</term>
<term>Authors jeadv</term>
<term>Autoimmune</term>
<term>Case number</term>
<term>Cosmetic</term>
<term>Cutaneous</term>
<term>Dermal</term>
<term>Dermalive</term>
<term>Dermaliver</term>
<term>Dermatol</term>
<term>Dermatol surg</term>
<term>Dermatology</term>
<term>European academy</term>
<term>Facial</term>
<term>Facial oedema</term>
<term>Granuloma</term>
<term>Granulomatous</term>
<term>Granulomatous reactions</term>
<term>Histological</term>
<term>Hyaluronic</term>
<term>Hyaluronic acid</term>
<term>Hypersensitivity</term>
<term>Hypersensitivity reactions</term>
<term>Implant</term>
<term>Injectable</term>
<term>Jeadv</term>
<term>Journal compilation</term>
<term>Juvederm</term>
<term>Lled</term>
<term>Ller</term>
<term>Ller material</term>
<term>Llers</term>
<term>Nasha</term>
<term>Nodule</term>
<term>Oedema</term>
<term>Other hand</term>
<term>Patient number</term>
<term>Plast</term>
<term>Plast reconstr surg</term>
<term>Recurrent bouts</term>
<term>Restylane</term>
<term>Restylaner</term>
<term>Rooster combs</term>
<term>Sarcoidosis</term>
<term>Sicca</term>
<term>Sicca syndrome</term>
<term>Silicone</term>
<term>Skin lesions</term>
<term>Soft tissue augmentation</term>
<term>Surg</term>
<term>Syndrome</term>
<term>Systemic complaints</term>
<term>Systemic manifestations</term>
<term>Vasculitis</term>
<term>Venereology</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Introduction Implantation of dermal filler for cosmetic purposes is becoming increasingly common worldwide. It is thought that hyaluronic acid (HA) alone or combined with acrylic hydrogels (HA‐AH) does not have severe nor persistent side‐effects. However, recent evidence may show that major, local and/or systemic, immediate or delayed adverse effects may appear in relation with its use. Objective To evaluate the clinical complaints, laboratory data, treatment and follow‐up of patients with delayed adverse effects related to HA and HA‐AH implant fillers. Design Prospective, case‐series study of patients filled with HA and HA‐AH compounds. Setting The study has been done in a tertiary, teaching university hospital. Patients We report on a series of 25 patients, 15 of them in prospective manner, with severe, delayed side‐effects related to HA‐AH. Inclusion criteria have been drawn up. Patients with immediate side‐effects were excluded. Patients were submitted to a clinical follow‐up, battery of blood tests and thorax X‐ray films. Besides, a review of the literature was made. We undertook a computed‐assisted (MEDLINE), National Library of Medicine, Bethesda, MD, USA, search of the literature from 1996 up to December 2005. Main outcome Clinical evaluation of granulomas, skin manifestations and other local and systemic immune‐mediated disorders possibly related to HA and HA‐AH fillers or their cumulative interaction with previously administered fillers. Results Of 25 cases, 16 were filled with HA alone and 9 with a HA‐AH compounds. Of 15 cases analysed and with long‐term follow‐up, 10 were filled with HA alone, and the remaining five were filled with a HA‐AH. Time latency average up to beginning of symptoms was 13.7 months. Three of these 15 cases had been filled before with silicone and another one with Artecoll. Tender nodules were seen in 14 patients. Systemic manifestations appeared in three cases. Laboratory abnormalities were noted in all studied cases. After 16‐month average follow‐up, seven patients seem to be cured, and six have recurrent bouts. Two cases were lost during follow‐up. Conclusion Although in some cases, these clinical complications might have been associated with previous fillers or with other unknown foreign bodies, we feel that, although infrequently, delayed and recurrent chronic inflammatory and granulomatous reactions may complicate HA and HA‐AH implant fillers.</div>
</front>
</TEI>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Catalogne</li>
</region>
<settlement><li>Barcelone</li>
</settlement>
</list>
<tree><country name="Espagne"><region name="Catalogne"><name sortKey="Alijotas Eig, J" sort="Alijotas Eig, J" uniqKey="Alijotas Eig J" first="J" last="Alijotas-Reig">J. Alijotas-Reig</name>
</region>
<name sortKey="Alijotas Eig, J" sort="Alijotas Eig, J" uniqKey="Alijotas Eig J" first="J" last="Alijotas-Reig">J. Alijotas-Reig</name>
<name sortKey="Alijotas Eig, J" sort="Alijotas Eig, J" uniqKey="Alijotas Eig J" first="J" last="Alijotas-Reig">J. Alijotas-Reig</name>
<name sortKey="Garcia Imenez, V" sort="Garcia Imenez, V" uniqKey="Garcia Imenez V" first="V" last="Garcia-Gimenez">V. Garcia-Gimenez</name>
<name sortKey="Garcia Imenez, V" sort="Garcia Imenez, V" uniqKey="Garcia Imenez V" first="V" last="Garcia-Gimenez">V. Garcia-Gimenez</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A12 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A12 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:17C84C26C6687775A7EDAF453BE1784DECA9F79C |texte= Delayed immune‐mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long‐term follow‐up and review of the literature }}
This area was generated with Dilib version V0.6.33. |